5-Hydroxymethyl-2′-deoxyuridine, but not temozolomide, enhances the selective synthetic lethality in BRCA1 and BRCA2-deficient cells caused by PARP inhibition

被引：1
|
作者：
Clement, Jean [1 ]
Nakamura, Jun [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4486
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4486
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations
    Dedes, Konstantin J.
    Wilkerson, Paul M.
    Wetterskog, Daniel
    Weigelt, Britta
    Ashworth, Alan
    Reis-Filho, Jorge S.
    CELL CYCLE, 2011, 10 (08) : 1192 - 1199
  • [2] PARP Inhibition by Flavonoids Induced Selective Cell Killing to BRCA2-Deficient Cells
    Su, Cathy
    Haskins, Alexis H.
    Omata, Chisato
    Aizawa, Yasushi
    Kato, Takamitsu A.
    PHARMACEUTICALS, 2017, 10 (04)
  • [3] Increasing the Synthetic Lethality of PARP Inhibition in Glioblastoma Cells by Depletion of Nuclear BRCA1
    Sizemore, S.
    Mohammad, R.
    Schnedl, B.
    Chakravarti, A.
    Xia, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S780 - S780
  • [4] BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality
    Khalizieva, Anna
    Moser, Sarah C.
    Bouwman, Peter
    Jonkers, Jos
    GENES & DEVELOPMENT, 2025, 39 (1-2) : 86 - 108
  • [5] Identification of a RAD52 Inhibitor Inducing Synthetic Lethality in BRCA2-Deficient Cancer Cells
    Yang, Qianye
    Li, Yu
    Sun, Rong
    Li, Jian
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells
    Baquero, Juan Miguel
    Marchena-Perea, Erik
    Mirabet, Rocio
    Torres-Ruiz, Raul
    Blanco-Aparicio, Carmen
    Rodriguez-Perales, Sandra
    Helleday, Thomas
    Benitez-Buelga, Carlos
    Benitez, Javier
    Osorio, Ana
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells
    Martino, Julieta
    Omar Siri, Sebastian
    Luis Calzetta, Nicolas
    Soledad Paviolo, Natalia
    Garro, Cintia
    Pansa, Maria F.
    Carbajosa, Sofia
    Brown, Aaron C.
    Luis Bocco, Jose
    Gloger, Israel
    Drewes, Gerard
    Madauss, Kevin P.
    Soria, Gaston
    Gottifredi, Vanesa
    ELIFE, 2023, 12
  • [8] Enhancing radiosensitisation of BRCA2-proficient and BRCA2-deficient cell lines with hyperthermia and PARP1-i
    Oei, Arlene L.
    Ahire, Vidhula R.
    van Leeuwenc, C. M.
    ten Cate, Rosemarie
    Stalpers, Lukas J. A.
    Crezee, Johannes
    Kok, H. Petra
    Franken, Nicolaas A. P.
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2018, 34 (01) : 39 - 48
  • [9] Evaluation of PARP inhibition as a platinum sparing strategy in Brca2-deficient pancreatic tumors.
    Lowery, Maeve Aine
    Lee, Alycia
    Tobias, Ethan
    Sung, Patricia
    Bhanot, Umeshkumar
    Shakya, Reena
    Ludwig, Thomas
    O'Reilly, Eileen Mary
    Jasin, Maria
    Moynahan, Mary Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
    Ilirjana Bajrami
    Callum Walker
    Dragomir B. Krastev
    Daniel Weekes
    Feifei Song
    Andrew J. Wicks
    John Alexander
    Syed Haider
    Rachel Brough
    Stephen J. Pettitt
    Andrew N. J. Tutt
    Christopher J. Lord
    Communications Biology, 4
12345